ENTITY

Neurovive Pharmaceutical Ab (NVP SS)

Analysis

Health Care • Sweden

NeuroVive Pharmaceutical AB researches and develops drugs for the treatment of traumatic brain injuries. The Company produces nerve cell-protecting and cyclosporine-based pharmaceuticals.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00